Early phase I study of non-viral CD19/CD22/BCMA tri-targeting JL-Lightning-CAR-T in relapsed/refractory B-cell non-Hodgkin's lymphoma.
Sign Up to like & getrecommendations! Published in 2025 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2025.43.16_suppl.e14521
Abstract: e14521 Background: Research indicates that CAR-T cell proliferation and persistence correlates with clinical responses, particularly in hematological malignancies. CAR-T cell stemness and exhaustion levels are determinants of in vivo expansion and persistence. The first in… read more here.
Keywords: cd19 cd22; car; tri targeting; lightning car ... See more keywords